Management of the Facial Nerve

  • Natalie L. Silver
  • Matthew L. Bush
  • Jeffrey N. Myers


Malignancies affecting the facial nerve are most commonly caused by advanced squamous cell carcinoma of the skin, primary temporal bone cancer, and primary or metastatic lesions of the parotid gland. Perineural spread along the facial nerve and preoperative facial nerve weakness are ominous findings and portend a poor prognosis. Treatment often requires aggressive multimodality management. Surgery, in resectable cases, followed by adjuvant radiation, is the primary treatment for temporal bone malignancies that involve the facial nerve. Careful preoperative planning and multidisciplinary management are imperative to maximize both oncologic and functional outcomes.


Temporal bone cancer Perineural invasion Perineural spread Facial nerve management Parotidectomy Squamous cell carcinoma of the external ear Parotid gland cancer 


  1. 1.
    May M, Schaitkin BM. History of facial nerve surgery. Facial Plast Surg. 2000;16(4):301–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Selesnick SH, Burt BM. Regional spread of nonneurogenic tumors to the skull base via the facial nerve. Otol Neurotol. 2003;24(2):326–33.PubMedCrossRefGoogle Scholar
  3. 3.
    Leonetti JP, Marzo SJ, Anderson DA, Sappington JM. Neoplastic causes of nonacute facial paralysis: a review of 221 cases. Ear Nose Throat J. 2016;95(9):390–404.PubMedGoogle Scholar
  4. 4.
    Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Iversen T, Tretli S. Trends for invasive squamous cell neoplasia of the skin in Norway. Br J Cancer. 1999;81(3):528–31.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;106(11):2389–96.PubMedCrossRefGoogle Scholar
  7. 7.
    Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005;23(4):759–65.CrossRefGoogle Scholar
  8. 8.
    Yoon M, Chougule P, Dufresne R, Wanebo HJ. Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg. 1992;164(6):574–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Byers R, Kesler K, Redmon B, Medina J, Schwarz B. Squamous carcinoma of the external ear. Am J Surg. 1983;146(4):447–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Afzelius LE, Gunnarsson M, Nordgren H. Guidelines for prophylactic radical lymph node dissection in cases of carcinoma of the external ear. Head Neck Surg. 1980;2(5):361–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Freedlander E, Chung FF. Squamous cell carcinoma of the pinna. Br J Plast Surg. 1983;36(2):171–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988–2000): the Rhode Island follow-back study. Arch Dermatol. 2004;140(7):837–42.PubMedCrossRefGoogle Scholar
  13. 13.
    Moody SA, Hirsch BE, Myers EN. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol. 2000;21(4):582–8.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Clairmont AA, Conley JJ. Primary carcinoma of the mastoid bone. Ann Otol Rhinol Laryngol. 1977;86(3 Pt 1):306–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Gidley PW. Ear and temporal bone cancer, chapter 23. In: Myers JN, Hanna EYN, Myers EN, editors. Cancer of the head and neck. 5th ed. Philadelphia: Wolters Kluwer; 2017. p. 537–60.Google Scholar
  16. 16.
    Gidley PW, Thompson CR, Roberts DB, DeMonte F, Hanna EY. The oncology of otology. Laryngoscope. 2012;122(2):393–400.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Vrielinck LJ, Ostyn F, van Damme B, van den Bogaert W, Fossion E. The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands. Int J Oral Maxillofac Surg. 1988;17(3):190–3.PubMedCrossRefGoogle Scholar
  18. 18.
    Eneroth CM. Facial nerve paralysis. A criterion of malignancy in parotid tumors. Arch Otolaryngol. 1972;95(4):300–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Frankenthaler RA, Luna MA, Lee SS, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg. 1991;117(11):1251–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Deschler DG, Eisele DW. Surgery for primary malignant parotid neoplasms. Adv Otorhinolaryngol. 2016;78:83–94.PubMedGoogle Scholar
  21. 21.
    Amit M, Eran A, Billan S, et al. Perineural spread in noncutaneous head and neck cancer: new insights into an old problem. J Neurol Surg B Skull Base. 2016;77(2):86–95.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Gandhi MR, Panizza B, Kennedy D. Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing “targeted” MRI with the histologic findings following surgery. Head Neck. 2011;33(4):469–75.PubMedCrossRefGoogle Scholar
  23. 23.
    Baulch J, Gandhi M, Sommerville J, Panizza B. 3T MRI evaluation of large nerve perineural spread of head and neck cancers. J Med Imaging Radiat Oncol. 2015;59(5):578–85.PubMedCrossRefGoogle Scholar
  24. 24.
    Ginsberg LE. Imaging of perineural tumor spread in head and neck cancer. Semin Ultrasound CT MR. 1999;20(3):175–86.PubMedCrossRefGoogle Scholar
  25. 25.
    Solares CA, Lee K, Parmar P, O’Rourke P, Panizza B. Epidemiology of clinical perineural invasion in cutaneous squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2012;146(5):746–51.PubMedCrossRefGoogle Scholar
  26. 26.
    Solares CA, Mason E, Panizza BJ. Surgical management of perineural spread of head and neck cancers. J Neurol Surg B Skull Base. 2016;77(2):140–9.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    NCCN Practice Guidelines in Oncology: Squamous Cell Skin Cancer. 2016.;
  28. 28.
    Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28(3):268–73.PubMedGoogle Scholar
  29. 29.
    Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):542–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Wierzbicka M, Kopec T, Szyfter W, Kereiakes T, Bem G. The presence of facial nerve weakness on diagnosis of a parotid gland malignant process. Eur Arch Otorhinolaryngol. 2012;269(4):1177–82.PubMedCrossRefGoogle Scholar
  31. 31.
    Gullane PJ, Havas TJ. Facial nerve grafts: effects of postoperative irradiation. J Otolaryngol. 1987;16(2):112–5.PubMedGoogle Scholar
  32. 32.
    DeRubeis DA, Woulfe J, Rosso D, et al. Case of the month: June 1997—a 42 year old man with left facial weakness. Brain Pathol. 1998;8(1):233–4.PubMedGoogle Scholar
  33. 33.
    Gidley PW, Roberts DB, Sturgis EM. Squamous cell carcinoma of the temporal bone. Laryngoscope. 2010;120(6):1144–51.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer. 2005;104(7):1408–17.PubMedCrossRefGoogle Scholar
  35. 35.
    Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27(10):843–50.PubMedCrossRefGoogle Scholar
  36. 36.
    Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84(5):1198–205.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Natalie L. Silver
    • 1
  • Matthew L. Bush
    • 2
  • Jeffrey N. Myers
    • 3
  1. 1.Department of OtolaryngologyUniversity of FloridaGainesvilleUSA
  2. 2.Department of Otolaryngology — Head and Neck SurgeryUniversity of Kentucky Medical CenterLexingtonUSA
  3. 3.Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations